Osteoporosis Treatment Beyond 5 Years

Angie SzumlinskiHealth, Studies

For more than 2 decades, bisphosphonate drugs have been a first-line therapy for preventing osteoporotic fractures, based on strong clinical evidence showing significant fracture risk reduction within the first 3 to 5 years of treatment. However, data regarding the optimal duration of bisphosphonate treatment to minimize fracture risk beyond this initial period of time are limited. In September 2015, a …